SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (636)5/6/1999 11:09:00 AM
From: William Whitehead Jr.  Read Replies (3) | Respond to of 2344
 
I hold a considerable amount as well - just wonder if it is possible that we are over estimating the impact of ASCO.

All of us here know what to expect from the bridging study, but does the market? Do they expect more than they will actually receive, such as some sort of feedback from the actual Phase III.

Just a thought.

Whitey,



To: Jibacoa who wrote (636)5/6/1999 8:00:00 PM
From: marvin friedman  Respond to of 2344
 
Bernard:

Thanks for holding my hand.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News